1,791,092 Shares in CME Group Inc. $CME Purchased by Jupiter Topco LLC

Posted by Brian Himes on Aug 26th, 2026

Jupiter Topco LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,791,092 shares of the financial services provider’s stock, valued at approximately $395,519,000. Jupiter Topco LLC owned 0.50% of CME Group at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Bridgewater Advisors Inc. bought a new stake in shares of CME Group during the 2nd quarter valued at $612,000. FLC Capital Advisors bought a new position in shares of CME Group in the 4th quarter worth about $2,122,000. Haverford Trust Co bought a new position in shares of CME Group in the 2nd quarter worth about $13,818,000. HighTower Advisors LLC lifted its position in CME Group by 6.9% during the 4th quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider’s stock valued at $96,376,000 after acquiring an additional 22,692 shares during the period. Finally, TD Private Client Wealth LLC boosted its stake in CME Group by 132.7% during the fourth quarter. TD Private Client Wealth LLC now owns 21,228 shares of the financial services provider’s stock worth $5,797,000 after acquiring an additional 12,105 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $277.32 on Wednesday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company’s 50-day moving average is $251.75 and its 200 day moving average is $279.35. The company has a market capitalization of $99.72 billion, a price-to-earnings ratio of 23.52, a price-to-earnings-growth ratio of 3.32 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group’s revenue was up .8% compared to the same quarter last year. During the same period last year, the business earned $2.96 EPS. Sell-side analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CME shares. Raymond James Financial restated an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. UBS Group dropped their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Barclays cut their price target on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 9th. Finally, Bank of America raised their price objective on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $288.56.

Read Our Latest Stock Report on CME Group

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.